{"id":"W2589130880","doi":"10.1093/annonc/mdw383.16","title":"Phase 1/2 study of the safety and clinical activity of durvalumab in patients with non-small cell lung cancer (NSCLC)","year":2016,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":38,"is_retracted":false,"has_abstract":false,"ca_institutions":"Université de Montréal; Hôpital Notre-Dame","funders":"","keywords":"Medicine; Durvalumab; Internal medicine; Pneumonitis; Discontinuation; Gastroenterology; Lung cancer; Response Evaluation Criteria in Solid Tumors; Phases of clinical research; Cancer; Surgery; Toxicity; Lung; Pembrolizumab; Immunotherapy","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001325958,0.001611478,0.001864499,0.0003365659,0.0004343631,0.0009473374,0.0007942031,0.001138017,0.003148004],"category_scores_gemma":[0.00100464,0.0006085131,0.001213163,0.0002516408,0.001003044,0.0009630224,0.000303523,0.003315295,0.0007723586],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001249468,"about_ca_system_score_gemma":0.001492383,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001252454,"about_ca_topic_score_gemma":0.003259808,"domain_scores_codex":[0.9996444,0.0001599627,0.00001325355,0.00006615442,0.00003153185,0.00008464514],"domain_scores_gemma":[0.9994119,0.0001090423,0.00009478832,0.00006274268,0.00003901053,0.0002824494],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.8166726,0.05529206,0.006999961,0.0005236265,0.001184405,0.0003189564,0.0002998176,0.002090631,0.04087941,0.0004174605,0.004359347,0.07096169],"study_design_scores_gemma":[0.6989099,0.2799261,0.01054271,0.00002313043,0.0004269823,0.000358084,0.00007638152,0.001510663,0.004870637,0.0003154985,0.003004794,0.00003503664],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.993992,0.001270077,0.0004216379,0.0004259814,0.0001152989,0.001229387,0.0009996854,0.00006106724,0.001484798],"genre_scores_gemma":[0.9900242,0.001090702,0.001361562,0.0007870122,0.0001433795,0.001474591,0.001956198,0.00003724108,0.003125041],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003148004,"threshold_uncertainty_score":0.01053107,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.05181691926919445,"score_gpt":0.4093947081574053,"score_spread":0.3575777888882108,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}